AU4375293A - Targeted activated species cytotoxicity - Google Patents

Targeted activated species cytotoxicity

Info

Publication number
AU4375293A
AU4375293A AU43752/93A AU4375293A AU4375293A AU 4375293 A AU4375293 A AU 4375293A AU 43752/93 A AU43752/93 A AU 43752/93A AU 4375293 A AU4375293 A AU 4375293A AU 4375293 A AU4375293 A AU 4375293A
Authority
AU
Australia
Prior art keywords
cytotoxicity
activated species
targeted activated
targeted
species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43752/93A
Other languages
English (en)
Inventor
Eric T. Fossel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
Beth Israel Hospital Association
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Hospital Association filed Critical Beth Israel Hospital Association
Publication of AU4375293A publication Critical patent/AU4375293A/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
    • A61K47/665—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU43752/93A 1992-05-13 1993-05-13 Targeted activated species cytotoxicity Abandoned AU4375293A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88247892A 1992-05-13 1992-05-13
US882478 1992-05-13

Publications (1)

Publication Number Publication Date
AU4375293A true AU4375293A (en) 1993-12-13

Family

ID=25380664

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43752/93A Abandoned AU4375293A (en) 1992-05-13 1993-05-13 Targeted activated species cytotoxicity

Country Status (2)

Country Link
AU (1) AU4375293A (fr)
WO (1) WO1993023080A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5526399A (en) * 1998-08-28 2000-03-21 University Of Bath, The Improvements in or relating to the treatment of lesions
DE69941459D1 (de) * 1998-08-28 2009-11-05 Univ Bath Bath Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
EP1226235A2 (fr) * 1999-10-22 2002-07-31 LESKOVAR, Peter Constructions cellulaires adaptees a l'immunotherapie, leur production et leur utilisation
US20210170044A1 (en) * 2017-11-16 2021-06-10 Antigenesis Llc Systems and methods for lysosome induced immunogenic cell death

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US4867973A (en) * 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
FR2550944B1 (fr) * 1983-08-23 1985-12-06 Sanofi Sa Association pharmaceutique a base d'anticorps anticellules tumorales et de conjugues cytotoxiques, appropriee notamment pour le traitement des cancers
US4975278A (en) * 1988-02-26 1990-12-04 Bristol-Myers Company Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
JPH0629196B2 (ja) * 1987-12-01 1994-04-20 甲子郎 梅村 超音波による腫瘍治療用生理作用増強剤
US4937183A (en) * 1988-02-03 1990-06-26 Cytogen Corporation Method for the preparation of antibody-fragment conjugates

Also Published As

Publication number Publication date
WO1993023080A1 (fr) 1993-11-25

Similar Documents

Publication Publication Date Title
AU3434393A (en) Targeted virus
AU4166393A (en) Auto-reclosers
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU3615593A (en) Improved mild soap-synbar
AU3042892A (en) Rockbolt
AU4177593A (en) Benzophenonehydrazones
AU685767B2 (en) Substituted benzazepinones
AU4156393A (en) Heterocyclyltriazolinones
AU3285893A (en) Pesticides
AU664253B2 (en) Photo-deviometer
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU3461693A (en) Saddle-cloth
AU4164793A (en) Heterocyclyltriazolinones
AU4314393A (en) Synergistic biocide-agent combinations
AU4632493A (en) Weathershed
AU4375293A (en) Targeted activated species cytotoxicity
AU4314493A (en) High-action antimicrobial biocide-agent combinations
AU3185693A (en) Pyrrolylbenzodiazepinones
AU4864693A (en) Alkoxymethyl-substituted pyridonebiphenyls
AU5708094A (en) Deterrent device
AU4316993A (en) Polyaniles
AU5564794A (en) Play-mark
AU5165993A (en) Pp14-based therapy
AU655709B2 (en) Wheel